Abstract:Background: Recently, several studies have suggested that abnormal quantity and function of regulatory T cells (Tregs) may play a vital role in the development of rheumatoid arthritis (RA). CD25+FOXP3+ T cells include CD4+ (CD4+ Tregs) and CD8+ cells (CD8+ Tregs). Recently studies have shown that CD8+ Tregs also have immunosuppressive function, similar to even stronger than CD4+ Tregs, and are more sensitive to IL-2 in vivo. However, the status of CD8+Treg cells in RA is unknown. Objectives: Our study was designed to clarify the level of CD4-CD25+FOXP3+ T cells in RA patients, and to investigate the role of low-dose interleukin-2 (IL-2) therapy in the regulation of CD4-CD25+FOXP3+ T cells in RA patients to provide another theoretical basis besides CD4+ Tregs to IL-2 therapy. Methods: Three hundred and four RA patients (diagnosis according to the 2010 ACR criteria) were enrolled; no treatment group (N = 75), DMARDs treatment group (N = 73), low dose IL-2 treatment group (50WIU/day × 5 days, subcutaneous injection) (N = 156), and healthy control group (N = 90). The absolute numbers of CD4-CD25+FOXP3+ T cells in peripheral blood were detected by flow cytometry. We assumed that CD4- T cells with CD25+ and FOXP3+ were mostly CD8+CD25+FOXP3+ Treg cells, which was CD4-CD25+FOXP3+ T cells in this study. The levels of CD4-CD25+FOXP3+ T cells among these groups were compared with that of health group or each other respectively, and then the statistical software SPSS 20.0 was used for analysis; p<0.05 was considered significant. Results: As compared with the healthy group, the absolute number of CD4-CD25+FOXP3+ T cells decreased significantly in the untreated RA patients [0.94(0.41,1.61) vs 1.31(0.72,2.52), P<0.001] and more dramatically in DMARDs treatment patients [0.86(0.36,1.83) vs 1.31(0.72,2.52), P<0.01]. After treatment with IL-2, the absolute count of CD4-CD25+FOXP3+ T cells increased significantly compared with that before treatment [0.91(0.48,1.54) vs 2.10(1.12,3.56), P<0.001]. Conclusions: The absolute number of CD4-CD25+FOXP3+ T cells in untreated RA patients were lower than those health, implying that CD4-CD25+FOXP3+ T cells deficiency was caused by disease itself but not immunosuppressive therapy, which may be an important factor in the pathogenesis of RA. The traditional DMARDs therapy did not improve this reduction. Low dose IL-2 can increase the absolute number of CD4-CD25+FOXP3+ T cells in peripheral blood. We are about to detect the number of CD8+CD25+FOXP3+ Treg cells accurately to verify this theory. Disclosure of Interest: None declared

Superhydrophobic conducting polymers based on hydrocarbon poly(3,4-ethylenedioxyselenophene).

Tgf-Beta-Induced Regulatory T Cells Directly Suppress B Cell Responses Through A Noncytotoxic Mechanism

New Insights on Ox40 in the Control of T Cell Immunity and Immune Tolerance in Vivo

The Role of STAT3 in Antigen-Igg Inducing Regulatory CD4+Foxp3+T Cells

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

CD8+ Regulatory T Cells Are Responsible for GAD‐IgG Gene‐transferred Tolerance Induction in NOD Mice

Combination treatment with fingolimod and a pathogenic antigen prevents relapse of glucose‐6‐phosphate isomerase peptide‐induced arthritis

GAD-IgG-inducing CD4+Foxp3+Treg Cells Suppressing Diabetes Are Involved in the Increasing Ratio of CD80+:CD86+ Cells in NOD Mice

Inhibition of follicular T-helper cells by CD8 + regulatory T cells is essential for self tolerance

Antigen-specific transforming growth factor β-induced Treg cells, but not natural Treg cells, ameliorate autoimmune arthritis in mice by shifting the Th17/Treg cell balance from Th17 predominance to Treg cell predominance.

Essential Roles Of Tgf-Beta In Anti-Cd3 Antibody Therapy: Reversal Of Diabetes In Nonobese Diabetic Mice Independent Of Foxp3(+) Cd4(+) Regulatory T Cells

SAT0163 Absolute Number of Peripheral Cd4-Cd25+foxp3+t Cells Decreases and Restores after Low-Dose Interleukin-2 Treatment in Rheumatoid Arthritis

Peripheral TIGIT+ T Follicular Helper Cells That Produce High Levels of Interleukin-21 via OX40 Represent Disease Activity in IgG4-Related Disease

CD69 enhances immunosuppressive function of regulatory T-cells and attenuates colitis by prompting IL-10 production

Intragraft memory-like CD127hiCD4+Foxp3+ Tregs maintain transplant tolerance

Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3

Increased immunosuppressive function of CD4(+)CD25(+)Foxp3(+)GITR+ T regulatory cells from NFATc2((-/-)) mice controls allergen-induced experimental asthma

Identification of the Subsets of IL-10-Producing Regulatory B Cells in the Course of Tolerance Induction and Maintenance in Islet Allotransplantation

Therapeutic Effects of TGF-β-induced Itregs on Established Autoimmune Diseases (115.3)

A distal Foxp3 enhancer enables interleukin-2 dependent thymic Treg cell lineage commitment for robust immune tolerance

Optimal Semi-Persistent Uplink Scheduling Policy for Large-Scale Antenna Systems